The global Recombinant DNA Technology Market was valued USD 142.9 Billion in 2021 and is all set to surpass USD 223.0 Billion by 2028, exhibiting a CAGR of 7.7% during the forecast period 2022-2028.

The market’s value in 2020 was USD 656.64 billion, and with an extremely high CAGR of 21.36% is expected to attain a value of USD 1.378 trillion by 2030 according to Strategic Market Research ...

After the development of recombinant DNA technology in the last two decades, various bispecific antibody formats have appeared to adapt to the preferred target–product profile.

A technology that uses enzymes to cut and paste together DNA sequences of interest. The recombined DNA sequences can be placed into vectors that carry the DNA into a host cell. In this host cell ...

Metabolic regulation : application of recombinant DNA techniques / edited by Alan G. Goodridge and Richard W. Hanson Smithsonian Libraries and Archives Object Details Author Goodridge, Alan G Hanson, ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...

Marketresearch.biz reports that the Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 743.6 Bn in 2022, growing at a CAGR of 5.8% during the forecast ...

In this interview, Amy Sheng discusses the current landscape of vaccine development and the use of recombinant technology.